MedPath

Treatment of respiratory distress syndrome in preterm infants

Phase 2
Conditions
eonatal respiratory distress syndrome.
Respiratory distress syndrome of newborn
P22.0
Registration Number
IRCT20160523028008N8
Lead Sponsor
Hamedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
112
Inclusion Criteria

Gestational age of 28-37 weeks
With distress syndrome
Requiring Fraction of inspired oxygen>40
Treatment with surfactant in less than 24 hours after birth

Exclusion Criteria

Suffering of congenital heart abnormalities
APGAR score<5
Suffering from any congenital disease

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Respiratory support. Timepoint: First week of birth. Method of measurement: Investigation of FIO2 and analysis of arterial blood gases.;Hospitalization duration. Timepoint: During hospitalization. Method of measurement: Review of infant medical records.;Mortality. Timepoint: During hospitalization. Method of measurement: Review of infant medical records.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath